C David Pendleton

Title: C David Pendleton: Innovator in Peptide Research

Introduction

C David Pendleton is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of peptide research. With a total of 5 patents to his name, Pendleton's work focuses on developing innovative solutions for immune responses and treatments related to viral infections.

Latest Patents

Pendleton's latest patents include groundbreaking inventions such as peptides that elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response, and T helper cell response across a broad range of MHC type recipients. One of his notable inventions involves peptide constructs comprised of multideterminant T helper peptides from the envelope glycoprotein of HIV. These constructs have been shown to induce proliferative responses in various haplotypes of mice and elicit IL-2 responses in a significant percentage of HIV-positive patients. Additionally, he has developed modified HCV peptide vaccines that provide methods for producing immune responses and treating or preventing HCV infections.

Career Highlights

Throughout his career, Pendleton has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has contributed to advancements in understanding and combating viral infections, particularly HIV and HCV.

Collaborations

Pendleton has collaborated with esteemed colleagues such as Jay A Berzofsky and Mutsunori Shirai, further enhancing the impact of his research in the scientific community.

Conclusion

C David Pendleton's innovative work in peptide research has led to significant advancements in the field of immunology. His contributions continue to influence the development of effective treatments for viral infections, showcasing the importance of innovation in medical science.